OClawVPS.com
Linden Capital Partners
Edit

Linden Capital Partners

https://www.lindenllc.com
Last activity: 16.07.2025
Active
Invests in categories: MedTechServiceProductHealthTechManufacturingDentalHardwareCareManagementProvider
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare.
News
161
Portfolio
46
Persons
68
Mentions
39
Location: United States, Illinois, Chicago
Employees: 51-200
Founded date: 2002
Investment Type: Private Equity Firm; Venture Capital
Investment Stage: Private Equity

Portfolio 46

DateNameWebsiteTotal RaisedLocation
14.03.2024Alcresta T...alcresta.com$79MUnited Sta...
23.07.2023The IMA Gr...theimagroup.com-United Sta...
21.05.2023Prescott&a...surgicalmicroscopes.com-United Sta...
30.03.2023Regenity B...regenity.com-United Sta...
10.12.2022LifeStyles...lifestylesglobal.com-United Sta...
29.10.2022Aspen Surg...aspensurgical.com-United Sta...
16.09.2022FinThrivefinthrive.com-United Sta...
19.08.2022Lab Logist...lablogistics.com-United Sta...
06.08.2022Aspirionaspirion.com-United Sta...
04.05.2022Specialty ...specialtynetworksllc.com-United Sta...
Show more

Persons 68

DateFirst NameLast NameTitleLinkedInLocation
-RickSlagerOperating ...linkedin.c...-
-NickGiannasiOperating ...linkedin.c...-
-MarkSullivanPartner, H...linkedin.c...-
-MikiKapoorOperating ...linkedin.c...-
-PiyushShuklaPartnerlinkedin.c...-
-JosephBernardoOperating ...linkedin.c...-
-ErnestWaaserOperating ...linkedin.c...-
-BrandonHeckPrincipal,...linkedin.c...-
-MargaretKeeganOperating ...linkedin.c...-
-AlyssaKnueController-
Show more

News 161

DateTitleDescription
12.03.2024Linden Invests in Alcresta TherapeuticsChicago, IL (March 12, 2024) – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced today the completion of its acquisition of Alcresta Therapeutics, Inc. (“Alcresta” or “the Company”), a leader in c...
08.02.2024Linden Capital Partners and Ontario Teachers’ Pension Plan Launch Initiative Focused on Clinical Research AdvancementChicago, IL and Toronto, Ont. (February 8, 2024) -Linden Capital Partners (Linden) and Ontario Teachers’ Pension Plan (Ontario Teachers’) are pleased to announce they are partnering on a transformative platform, led by Dr. John Potthoff, wi...
07.02.2024MeriCal Names Eric Bauer CEO and Appoints Jim Hamilton to Board of DirectorsAnaheim, CA (February 7, 2024) – MeriCal, LLC (“MeriCal”), a developer, manufacturer, and packager of probiotic and other nutritional supplements, is pleased to announce the appointments of Eric Bauer as CEO and Jim Hamilton as member of th...
31.01.2024Linden Agrees to Sell Specialty Networks to Cardinal HealthChicago, IL (January 31, 2024) – Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced today an agreement to sell Specialty Networks, LLC (“Specialty Networks”) to Ca...
31.08.2023Dae Hong joins StatLab as Chief Executive OfficerMcKinney, TX (August 31, 2023) – StatLab Medical Products (“StatLab” or “the Company”), a developer and manufacturer of diagnostic supplies and equipment, is pleased to announce that its Board of Directors has appointed Sung-Dae (Dae) Hong ...
10.08.2023Linden Welcomes René Lorenz as Operating Partner, Further Strengthening Pharma Services FocusChicago, IL (August 8, 2023) – Linden Capital Partners, a Chicago-based private equity firm focused exclusively on healthcare, is pleased to announce the appointment of René Lorenz as an Operating Partner. Mr. Lorenz brings over 38 years of...
29.03.2023Collagen Matrix is now Regenity BiosciencesParamus, NJ (March 29, 2023) – Collagen Matrix, Inc., a provider of regenerative medicine and a Linden Capital Partners (“Linden”) portfolio company, announced today it has changed its name to Regenity Biosciences (“Regenity”) and unveiled ...
22.02.2023Nick Giannasi joins Linden as an Operating PartnerChicago, IL (February 13, 2023) – Linden Capital Partners, a Chicago-based private equity firm focused exclusively on healthcare, today announced that Nick Giannasi joined the firm as an Operating Partner. Mr. Giannasi will support Linden’s...
19.12.2022Linden Agrees to Sell Spear Education to Avista Capital PartnersChicago, IL (December 19, 2022) – Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced today an agreement to sell Spear Education, LLC (“Spear” or the “Company”) to ...
01.12.2022Linden Acquires LifeStyles HealthcareAnnounces Laurent Faracci as incoming CEO and Linden Operating Partner Ron Fugate as Chairman
Show more

Mentions in press and media 39

DateTitleDescription
16.07.2025Klick Group Receives Investment From Linden Capital Partners and GICKlick Group, a Toronto, Canada-based independent commercialization partner for life sciences, received a growth investment from Linden Capital Partners and GIC. The amount of the deal was not disclosed. The company intends to use the funds ...
23.04.2025Linden Capital Partners: A Healthcare Powerhouse Rises with $5.4 Billion Fund VIIn the bustling world of private equity, few names resonate like Linden Capital Partners. Based in Chicago, this firm has carved a niche in the healthcare sector, and its latest achievement is nothing short of monumental. With the closing o...
21.04.2025Linden: Fund VI Closed At $5.4 BillionLinden Capital Partners, a Chicago-based healthcare private equity firm, announced the completion of the fundraise for its sixth buyout fund, Linden Capital Partners VI, with $5.2 billion of LP commitments and a $200 million GP commitment. ...
16.04.2025Linden Closes Fund VI, at $5.4 BillionLinden Capital Partners, a Chicago, IL-based healthcare private equity firm, closed its Fund VI, at $5.4 Billion. Fund VI will continue Linden’s strategy of seeking to drive long-term, sustainable growth through integrated operational exper...
30.12.2024Vital Care Receives Strategic Investment From Berkshire Partners, Leonard Green & Partners,and Linden Capital PartnersPartnership Will Offer Growth Opportunities for Leading Network of Infusion Pharmacy Franchisees Brentwood, TN – August 1, 2024 – Vital Care, a leading franchisor of infusion therapy pharmacies, announced today that it has closed a strategi...
02.10.2024Pfizer's Strategic Shift: Selling Haleon Shares and Precision Medicine's New LeadershipIn the ever-evolving landscape of pharmaceuticals, companies often pivot to stay ahead. Pfizer is making waves again. The pharmaceutical giant has announced a significant move: selling its stake in Haleon, the maker of Sensodyne, for a stag...
01.10.2024Precision Medicine Group Welcomes Margaret Keegan as CEO-- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors -- BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider...
04.09.2024Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical StudyMulticenter Clinical Study Demonstrates Benefits of Regenity's Novel Crosslinked Collagen Membrane Compared to Geistlich Bio-Gide® Collagen Membrane and Enables Launch into China PARAMUS, N.J., Sept. 4, 2024 /PRNewswire/ -- Regenity Bioscie...
29.05.2024Linden Capital Partners Receives Minority Investment from Blue Owl’s GP Strategic Capital Platform and LunateLinden Capital Partners, a Chicago, IL-based healthcare private equity firm, received a minority investment from Blue Owl (NYSE: OWL)’s GP Strategic Capital platform and Lunate Capital via their joint venture. The amount of the deal was not...
13.05.2024Alcresta Therapeutics Announces Commercial Availability of Next-Generation RELiZORB® (iMMOBILIZED LIPASE) CartridgeCommercial availability of RELiZORB marks important step to supporting more tube-fed patients including those living with short bowel syndrome and other rare diseases. WALTHAM, Mass., May 13, 2024 /PRNewswire/ -- Alcresta Therapeutics, Inc....
Show more

Reviews 0

Sign up to leave a review

Sign up Log In